• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.用一种简单方法评估补体介导的对卡他莫拉菌(布兰汉菌)分离株的杀伤作用。
Clin Diagn Lab Immunol. 1995 May;2(3):365-8. doi: 10.1128/cdli.2.3.365-368.1995.
2
Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis.补体抗性是卡他布兰汉菌(摩拉菌)的一种毒力因子。
FEMS Immunol Med Microbiol. 1995 Jun;11(3):207-11. doi: 10.1111/j.1574-695X.1995.tb00118.x.
3
Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.耐补体和敏感补体的卡他莫拉菌(布兰汉菌)菌株之间补体激活的差异发生在膜攻击复合物形成水平。
Infect Immun. 1994 Feb;62(2):589-95. doi: 10.1128/iai.62.2.589-595.1994.
4
Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.成人和儿童卡他莫拉菌(布兰汉菌)的呼吸道携带率及从痰液中分离出卡他莫拉菌的解读
J Clin Microbiol. 1990 Dec;28(12):2674-80. doi: 10.1128/jcm.28.12.2674-2680.1990.
5
Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development.卡他莫拉菌的毒力决定因素:分布及疫苗研发考量
Microbiology (Reading). 2017 Oct;163(10):1371-1384. doi: 10.1099/mic.0.000523. Epub 2017 Sep 12.
6
Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.卡他莫拉菌的脂寡糖P(k)(半乳糖α1-4半乳糖β1-4葡萄糖)表位是抵抗正常人血清介导的杀菌活性的一个因素。
Infect Immun. 2000 Sep;68(9):5261-8. doi: 10.1128/IAI.68.9.5261-5268.2000.
7
[Branhamella (Moraxella) catarrhalis--a clinically relevant pathogen of bronchopulmonary diseases?].[卡他布兰汉菌(莫拉菌属)——支气管肺部疾病的一种临床相关病原体?]
Z Erkr Atmungsorgane. 1991;177(1-2):82-7.
8
Branhamella catarrhalis: an organism gaining respect as a pathogen.卡他布兰汉菌:一种日益受到重视的病原菌。
Clin Microbiol Rev. 1990 Oct;3(4):293-320. doi: 10.1128/CMR.3.4.293.
9
PRELP Enhances Host Innate Immunity against the Respiratory Tract Pathogen .PRELP增强宿主对呼吸道病原体的固有免疫力。
J Immunol. 2017 Mar 15;198(6):2330-2340. doi: 10.4049/jimmunol.1601319. Epub 2017 Feb 1.
10
Complement evasion by the human respiratory tract pathogens Haemophilus influenzae and Moraxella catarrhalis.人体呼吸道病原体流感嗜血杆菌和卡他莫拉菌的补体逃避机制。
FEBS Lett. 2020 Aug;594(16):2586-2597. doi: 10.1002/1873-3468.13758. Epub 2020 Mar 9.

引用本文的文献

1
Novel Moraxella catarrhalis prophages display hyperconserved non-structural genes despite their genomic diversity.新型卡他莫拉菌噬菌体尽管基因组存在多样性,但仍显示出高度保守的非结构基因。
BMC Genomics. 2015 Oct 24;16:860. doi: 10.1186/s12864-015-2104-1.
2
Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.黏膜免疫接种卡他莫拉菌孔蛋白 m35 可增强肺部细菌清除:调理吞噬作用的可能作用。
Front Immunol. 2011 May 16;2:13. doi: 10.3389/fimmu.2011.00013. eCollection 2011.
3
The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.一种新型病原体:血清抗性卡他莫拉菌的出现与传播。
Genome Res. 2007 Nov;17(11):1647-56. doi: 10.1101/gr.6122607. Epub 2007 Sep 25.
4
Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children.肺炎球菌疫苗接种不影响儿童卡他莫拉菌分离株的遗传多样性。
Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):801-3. doi: 10.1007/s10096-004-1217-2.
5
Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.欧洲卡他莫拉菌分离株中BROβ-内酰胺酶的产生及对补体的抗性
J Clin Microbiol. 2002 Apr;40(4):1546-8. doi: 10.1128/JCM.40.4.1546-1548.2002.
6
Phage antibodies obtained by competitive selection on complement-resistant Moraxella (Branhamella) catarrhalis recognize the high-molecular-weight outer membrane protein.通过对耐补体的卡他莫拉菌(布兰汉菌属)进行竞争性筛选获得的噬菌体抗体可识别高分子量外膜蛋白。
Infect Immun. 1998 Jan;66(1):83-8. doi: 10.1128/IAI.66.1.83-88.1998.

本文引用的文献

1
Outbreak of Moraxella catarrhalis in a respiratory unit.
Thorax. 1993 Jan;48(1):91-2. doi: 10.1136/thx.48.1.91.
2
Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation.耐补体和敏感补体的卡他莫拉菌(布兰汉菌)菌株之间补体激活的差异发生在膜攻击复合物形成水平。
Infect Immun. 1994 Feb;62(2):589-95. doi: 10.1128/iai.62.2.589-595.1994.
3
Complement resistance in Branhamella (Moraxella) catarrhalis.卡他布兰汉菌(莫拉菌属)的补体抗性
Lancet. 1993 May 15;341(8855):1281. doi: 10.1016/0140-6736(93)91185-o.
4
Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.细菌对补体介导杀伤的抗性机制研究。IV. C5b-9与血清抗性淋病奈瑟菌而非血清敏感淋病奈瑟菌的细菌外膜成分形成高分子量复合物。
J Immunol. 1983 Sep;131(3):1443-51.
5
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.血清对革兰氏阴性菌的杀菌和溶菌活性。
Microbiol Rev. 1983 Mar;47(1):46-83. doi: 10.1128/mr.47.1.46-83.1983.
6
A plaque assay on agar for detection of gram-negative bacilli sensitive to complement.用于检测对补体敏感的革兰氏阴性杆菌的琼脂平板噬菌斑试验。
J Immunol. 1972 Nov;109(5):1156-8.
7
Development of bactericidal antibody during Branhamella catarrhalis infection.卡他布兰汉菌感染过程中杀菌抗体的产生
J Infect Dis. 1985 May;151(5):878-82. doi: 10.1093/infdis/151.5.878.
8
Branhamella catarrhalis respiratory infections.卡他布兰汉菌呼吸道感染
Rev Infect Dis. 1987 Nov-Dec;9(6):1140-9. doi: 10.1093/clinids/9.6.1140.
9
A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.通过限制性内切酶分析确诊的卡他布兰汉菌医院内暴发。
J Infect Dis. 1988 May;157(5):996-1001. doi: 10.1093/infdis/157.5.996.
10
Production of haemolysin, aerobactin and enterobactin by strains of Escherichia coli causing bacteraemia in cancer patients, and their resistance to human serum.
Res Microbiol. 1989 Jan;140(1):21-6. doi: 10.1016/0923-2508(89)90055-7.

用一种简单方法评估补体介导的对卡他莫拉菌(布兰汉菌)分离株的杀伤作用。

Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

作者信息

Verduin C M, Hol C, Van Dijke E, Faber J A, Jansze M, Verhoef J, Van Dijk H

机构信息

Eijkman-Winkler Institute for Medical and Clinical Microbiology, Faculty of Medicine, Utrecht University Hospital, The Netherlands.

出版信息

Clin Diagn Lab Immunol. 1995 May;2(3):365-8. doi: 10.1128/cdli.2.3.365-368.1995.

DOI:10.1128/cdli.2.3.365-368.1995
PMID:7664184
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC170161/
Abstract

Recently, we showed that complement resistance is an important virulence factor of Moraxella (Branhamella) catarrhalis. Our study used a serum bactericidal assay to determine complement resistance in M. catarrhalis. Although the serum bactericidal assay is considered the "gold standard" for determining complement resistance, it is laborious and time-consuming and therefore not well suited for large-scale studies. Using a large number (n = 324) of M. catarrhalis isolates obtained from the sputa of patients with lower respiratory tract infections (n = 200) and young carriers (n = 124), we assessed the value of a simple "culture-and-spot" test as an alternative to the serum bactericidal assay. For both groups of isolates, the degree of concordance between the two tests used was very significant (P < 0.0001). The agreement between the two assays was estimated to be "excellent beyond chance" (as determined by Cohen's kappa test). The culture-and-spot assay is a valuable alternative to the serum bactericidal assay, not only for screening purposes as shown here but also for studying the mechanism of complement resistance in M. catarrhalis at the molecular level.

摘要

最近,我们发现补体抗性是卡他莫拉菌(莫拉菌属布兰汉菌)的一个重要毒力因子。我们的研究采用血清杀菌试验来测定卡他莫拉菌的补体抗性。尽管血清杀菌试验被认为是测定补体抗性的“金标准”,但它既费力又耗时,因此不太适合大规模研究。我们使用从下呼吸道感染患者(n = 200)和年轻携带者(n = 124)的痰液中获得的大量(n = 324)卡他莫拉菌分离株,评估了一种简单的“培养与点样”试验作为血清杀菌试验替代方法的价值。对于两组分离株,所使用的两种试验之间的一致性程度非常显著(P < 0.0001)。两种测定方法之间的一致性估计为“极佳,并非偶然”(由科恩kappa检验确定)。“培养与点样”试验是血清杀菌试验的一种有价值的替代方法,不仅可用于此处所示的筛查目的,还可用于在分子水平上研究卡他莫拉菌补体抗性的机制。